Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
19.65
+0.13 (0.67%)
Feb 24, 2026, 3:00 PM CST
Market Cap8.13B -15.0%
Revenue (ttm)677.51M -57.9%
Net Income-170.53M
EPS-0.41
Shares Out413.66M
PE Ration/a
Forward PE13.10
Dividend0.17 (0.87%)
Ex-Dividend DateJun 18, 2025
Volume1,122,518
Average Volume3,434,771
Open19.61
Previous Close19.52
Day's Range19.56 - 19.76
52-Week Range18.83 - 26.30
Beta0.05
RSI38.49
Earnings DateMar 12, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

In 2024, SHA:688276's revenue was 1.23 billion, a decrease of -32.64% compared to the previous year's 1.82 billion. Earnings were 232.09 million, a decrease of -53.67%.

Financial Statements